ArticleScientific reports2026
Spatulated umbilical cord technique embracing Wharton's jelly for gastroschisis repair.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose was to prospectively analyze outcomes of gastroschisis closure using the Spatulated Umbilical Cord technique (SUCT). In SUCT, the umbilical cord is split open and used to cover the abdominal defect. The procedure involved opening the amnion layer from the base, exposing Wharton’s jelly and ‘spatulating’ using longitudinal incisions and securing it as a patch over the defect. A pilot interventional study was conducted prospectively at 3 centres from 2016 to 2023 with follow-up till 2024. The inclusion criteria included uncomplicated gastroschisis, where primary fascial closure was at risk of developing compartment syndrome (CS). The outcome measures were success rates (no CS), post-operative ventilation, days of parenteral nutrition (PN), time to full enteral feeds and complications. SUCT was successful in 80% (8/10) of the total cases. The median (min/max range) duration of mechanical ventilation required in 8 patients was 3(2–6) days. Two patients did not require mechanical ventilation. The median (min/max range) time-to-start enteral feeds(n = 9) was 8 (2–11) days and time to achieve goal enteral feeding (n = 9) was 20(5–48) days. Partial PN(n = 8) was given for 17(10–46) days. 2/10 patients needed re-laparotomy following CS, one succumbed. Other complications included wound infection (2/10), intestinal obstruction (1/10), persistent umbilical hernia (1/10), and sepsis-associated mortality (1/10). At a median follow-up of 61(36–92) months, 8 survivors were healthy. To conclude, SUCT is safe and feasible. Mesenchymal stromal cells from Wharton’s jelly have wound-healing properties through paracrine signalling and enhanced migration of fibroblasts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.